Balance Sheet
Accounts PayablesAccumulated DepreciationAssetsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

60 Degrees Pharmaceuticals (SXTP) Shares Outstanding (2022 - 2025)

60 Degrees Pharmaceuticals (SXTP) has disclosed Shares Outstanding for 4 consecutive years, with $76480.0 as the latest value for Q3 2025.

  • On a quarterly basis, Shares Outstanding changed 0.0% to $76480.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $76480.0, a 0.0% change, with the full-year FY2024 number at $566908.0, up 619.4% from a year prior.
  • Shares Outstanding was $4.1 million for Q3 2025 at 60 Degrees Pharmaceuticals, up from $76480.0 in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $4.1 million in Q3 2025 to a low of $39768.0 in Q4 2022.
  • A 4-year average of $1.0 million and a median of $147508.5 in 2023 define the central range for Shares Outstanding.
  • Peak YoY movement for Shares Outstanding: soared 619.4% in 2024, then tumbled 99.35% in 2025.
  • 60 Degrees Pharmaceuticals' Shares Outstanding stood at $39768.0 in 2022, then skyrocketed by 98.16% to $78803.0 in 2023, then skyrocketed by 619.4% to $566908.0 in 2024, then crashed by 86.51% to $76480.0 in 2025.
  • Per Business Quant, the three most recent readings for SXTP's Shares Outstanding are $76480.0 (Q3 2025), $76480.0 (Q2 2025), and $76480.0 (Q1 2025).